An Open-label, 2-period, drug-drug interaction study, evaluating pharmacokinetic interaction between letermovir and posaconazole in healthy female subjects

Trial Profile

An Open-label, 2-period, drug-drug interaction study, evaluating pharmacokinetic interaction between letermovir and posaconazole in healthy female subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Letermovir (Primary) ; Posaconazole
  • Indications Cytomegalovirus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Mar 2018 Results assessing pharmacokinetics and tolerability of letermovir coadministered with azole antifungals (posaconazole or voriconazole) in healthy subjects in two phase1 trials, were published in the journal of clinical pharmacology.
    • 30 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top